Guideline for the management of upper respiratory tract infections

South African Medical Journal

Volumn 94, Issue 6 II, 2004, Pages 475-482

  Brink, A J ^j   Cotton, M F ^a   Feldman, C ^b   Geffen, L ^c   Hendson, W ^d   Hockman, M H ^e   Maartens, G ^f   Madhi, S A ^g   Mutua Mpungu, M ^h   Swingler, G H ⁱ  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c SA Academy of Family Practice/Primary Care   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Linksfield Park Clinic   (South Africa)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g NICD   (South Africa)

^h SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j Ampath Trust   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFACLOR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DECONGESTIVE AGENT; ERYTHROMYCIN ESTOLATE; GATIFLOXACIN; IBUPROFEN; KETOLIDE; LORACARBEF; MACROLIDE; MOXIFLOXACIN; PARACETAMOL; PENICILLIN G; PENICILLIN V POTASSIUM; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; UNINDEXED DRUG;

ADULT; ANGIONEUROTIC EDEMA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DAY CARE; DRUG ERUPTION; EPSTEIN BARR VIRUS; HAEMOPHILUS INFLUENZAE; HEALTH CARE MANAGEMENT; HUMAN; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICAL SOCIETY; MORAXELLA CATARRHALIS; OTITIS MEDIA; PENICILLIN ALLERGY; PENICILLIN RESISTANCE; PHARYNGITIS; PRACTICE GUIDELINE; RANDOMIZATION; RHEUMATIC FEVER; SINUSITIS; SKIN ALLERGY; SOUTH AFRICA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SYMPOSIUM; THROAT CULTURE; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; URTICARIA;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; COMMON COLD; DRUG RESISTANCE, BACTERIAL; HUMANS; OTITIS MEDIA; PHARYNGITIS; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SINUSITIS; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; TONSILLITIS;

EID: 3042855288     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Jacobs MR. World trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 2003; 22: S109-S119.
2. Del Mar C. Managing sore throat: a literature review. Med J Aust 1992; 156: 572-575.
3. Del Mar CB, Galsziou PP, Spinks AB. Antibiotics for sore throat (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, 2003.
4. Pechere JC. Parameters important in short antibiotic courses. J Int Med Res 2000; 28: suppl 1, 3A-12A.
5. Huebner RE, Wasas AD, Hockman M, et al. Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol 2003; 117: 169-172.
6. Graham A, Fahey T. Sore throat: diagnostic and therapeutic dilemmas. BMJ 1999; 319: 173-174.
7. Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr 1992; 121: 569-572.
8. Bass JW. A review of the rationale and advantages of various mixtures of benzathine penicillin G. Pediatrics 1996; 97: 960-963.
9. Dicuonzo G. Fiscarelli E, Gherardi G, et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 2002; 46: 3987-3990.
10. Reinert RR, Lutticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus penumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 2003; 47: 489-493.
11. American Academy of Pediatrics. Group A streptococcal infections. In: Pickering LK, ed. Red Book: 2003 Report of the Committee of Infectious Diseases. Elk Grove Village, Ill.: American Academy of Pediatrics, 2003: 578-580.
12. Adam D, Scholz H, Helmerking M. Short course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillo-pharyngitis and incidence of poststreptococcal sequelae. J Infect Dis 2000; 182: 509-516.
13. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10: 275-281.
14. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Drugs Exp Clin Res 1987; 13: 91-94.
15. Portier H, Chavanet P, Gouyon JB, et al. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 1990; 26: 79-85.
16. Mehra S, van Moerkerke M, Welck J, et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J 1998; 17: 452-457.
17. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680-695.
18. Hoppe HL, Johnson CE. Otitis media: focus on antimicrobial resistance and new treatment options. Am J Health Syst Pharm 1998; 55(18): 1881-1897.
19. Marchant CD, Carlin SA, Johnson CE, et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". J Pediatr 1992; 120: 72-77.
20. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997; 314: 1526-1529.
21. Pichichero ME. Diagnostic accuracy of otitis media and tympanocentesis skills assessment among pediatricians. Eur J Clin Microbiol Infect Dis 2003; 22: 519-524.
22. Bradley JS, Nelson JD. Nelson's Pocketbook of Pediatric Antimicrobial Therapy. Lippincott Williams and Wilkins, 2002. www.skyscape.com (accessed March 2004).
23. Turner D, Leibovitz E, Aran A, et al. Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 2002; 21: 669-674.
24. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/ clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829-837.
25. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255-259.
26. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J 1998; 17: 1126-1131.
27. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000; 44: 43-50.
28. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 2001; 20: 260-264.
29. Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children. A study of the duration of treatment. Acta Otolaryngol 1982; 94: 283-287.
30. Leibovitz E, Dagan R. Otits media therapy and drug resistance. Infect Med 2001; 18: 263-270.
31. Dunbar LM. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance. Am J Med Sci 2003; 326: 360-368.
32. Gwaltney JM, Jr., Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457-461.
33. Siegert R, Gehanno P, Nikolaidis P, et al. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med 2000; 94: 337-344.
34. Sher LD, McAdoo MA, Bettis RB, et al. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Clin Ther 2002; 24: 269-281.
35. Roos K, Brunswig-Pitschner C, Kostrica R, et al. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis. Chemotherapy 2002; 48: 100-108.
36. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345: 804-809.